Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence and Prognosis of Cardiac Amiloidosis in Turkey- Registry Study

NCT04915235 is registered in ClinicalTrials.gov with Turkish Society of Cardiology as lead sponsor.

NCT NCT04915235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04915235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence and Prognosis of Cardiac Amiloidosis in Turkey- Registry Study
Lead sponsor
Turkish Society of Cardiology
Phase
Observational
Overall status
Unknown status
Start date
September 18, 2020
Completion date
December 31, 2025
Enrollment
2,087 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis